EUVIMEDEUVIMED entdecken
Crossref

Acquired Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand (TRAIL) Resistance of Human Colorectal Cancer Cells Is Linked to Histone Acetylation and Is Synergistically Ameliorated by Combination with HDAC Inhibitors

Se Lim Kim, MinWoo Shin, Byung Chul Jin, SeungYoung Seo, Gi Won Ha, Sang Wook Kim

Digestive Diseases and Sciences · 2024-09 · 69 (9) · 3305-3317

DOI: 10.1007/s10620-024-08569-5 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Digestive Diseases and Sciences, online erschienen am 01.08.2024. Verfasst von Se Lim Kim und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Jeonbuk National University Medical School, Research Institute of Clinical Medicine of Jeonbuk National University, …. Hauptthemen laut MEDLINE: TNF-Related Apoptosis-Inducing Ligand, Histone Deacetylase Inhibitors, Colorectal Neoplasms, Drug Resistance, Neoplasm. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 61 Literaturangaben. Gefördert von: National Research Foundation of Korea, research funds for newly appointed professors of Jeonbuk National University, Fund of the Biomedical Research Institute of Jeonbuk National University Hospital.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) is an attractive target for the treatment of various malignancies; however, its therapeutic potential is limited because of the frequent occurrence of tumor cell resistance. In this study, we determined whether TRAIL resistance acquired by repeated administration could be overcome by HDAC inhibition in human colorectal cancer cells. METHODS: TRAIL-resistant HCT116 human colorectal cancer cells (HCT116-TR) were generated by repeated treatment with 10 and 25 ng/mL TRAIL twice weekly for 28 days. RESULTS: The resulting TRAIL-resistant cells were noncross-resistant to other chemotherapeutic agents. The levels of histone acetylation-related proteins, such as ac-histone H4 and HDAC1, were altered in HCT116-TR cells compared with the parental HCT116 cell line. The combined treatment with TRAIL and HDAC inhibitors significantly increased apoptosis in HCT116-TR cells and indicated a synergistic effect. The mechanism by which HDAC inhibition sensitizes HCT116-TR cells to TRAIL is dependent on the intrinsic pathway. In addition, we found that HDAC inhibition enhanced the sensitivity of cells to TRAIL through mitogen-activated protein kinases/CCAAT/enhancer-binding protein homologs of protein-dependent upregulation of death receptor 5. CONCLUSION: These results suggest that histone acetylation is responsible for acquired TRAIL resistance after repeated exposure and acquired resistance to TRAIL may be overcome by combination therapies with HDAC inhibitors.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

TNF-Related Apoptosis-Inducing LigandHistone Deacetylase InhibitorsColorectal NeoplasmsDrug Resistance, NeoplasmHistonesDrug SynergismApoptosisHumansAcetylationHCT116 Cells

Stichwörter der Autor:innen

ApoptosisCCAAT/enhancer-binding protein homologs proteinColorectal cancerHDAC inhibitorsMitogen-activated protein kinasesTRAIL resistance

Substanzen

TNF-Related Apoptosis-Inducing LigandHistone Deacetylase InhibitorsHistonesTNFSF10 protein, human

Autor:innen und Institutionen

  • Department of Internal Medicine, Jeonbuk National University Medical School, Research Institute of Clinical Medicine of Jeonbuk National University, 20, Geonji-Ro, Deokjin-Gu, Jeonju, Jeonbuk, 54907, Republic of Korea.
  • Biomedical Research Institute of Jeonbuk National University Hospital, Jeonju, Korea.
  • Department of Surgery, Jeonbuk National University Medical School, Research Institute of Clinical Medicine of Jeonbuk National University, 20, Geonji-Ro, Deokjin-Gu, Jeonju, Jeonbuk, 54907, Republic of Korea.
  • Department of Internal Medicine, Jeonbuk National University Medical School, Research Institute of Clinical Medicine of Jeonbuk National University, 20, Geonji-Ro, Deokjin-Gu, Jeonju, Jeonbuk, 54907, Republic of Korea.…
  • Biomedical Research Institute of Jeonbuk National University Hospital, Jeonju, Korea. clickm@jbnu.ac.kr.

Förderung

  • National Research Foundation of Korea
  • research funds for newly appointed professors of Jeonbuk National University
  • Fund of the Biomedical Research Institute of Jeonbuk National University Hospital

Zitieren

APA

Kim, S. L., Shin, M., Jin, B. C., Seo, S., Ha, G. W., & Kim, S. W. (2024). Acquired Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand (TRAIL) Resistance of Human Colorectal Cancer Cells Is Linked to Histone Acetylation and Is Synergistically Ameliorated by Combination with HDAC Inhibitors. Digestive Diseases and Sciences, 69(9), 3305-3317. https://doi.org/10.1007/s10620-024-08569-5

Vancouver

Kim SL, Shin M, Jin BC, Seo S, Ha GW, Kim SW. Acquired Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand (TRAIL) Resistance of Human Colorectal Cancer Cells Is Linked to Histone Acetylation and Is Synergistically Ameliorated by Combination with HDAC Inhibitors. Digestive Diseases and Sciences. 2024;69(9):3305-3317. doi:10.1007/s10620-024-08569-5

BibTeX
@article{Kim2024,
  author = {Kim, Se Lim and Shin, MinWoo and Jin, Byung Chul and Seo, SeungYoung and Ha, Gi Won and Kim, Sang Wook},
  title = {Acquired Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand (TRAIL) Resistance of Human Colorectal Cancer Cells Is Linked to Histone Acetylation and Is Synergistically Ameliorated by Combination with HDAC Inhibitors},
  journal = {Digestive Diseases and Sciences},
  year = {2024},
  volume = {69},
  number = {9},
  pages = {3305--3317},
  doi = {10.1007/s10620-024-08569-5}
}
Kostenlos starten →